Pleural Effusion Diagnosis, Treatment & Cost

PACE Hospitals offers advanced pleural effusion treatment in Hyderabad, India, managing all types including bilateral, malignant, loculated, and mild pleural effusion. Our specialists ensure accurate diagnosis through clinical evaluation, pleural fluid analysis, and imaging such as chest X-ray and ultrasound.


We provide personalized treatment based on the underlying cause, covering right, left, and bilateral pleural effusion cases with both medical and interventional care. Our focus is on symptom relief, preventing complications, and restoring optimal lung function across all age groups.

Book Appointment for Pleural Effusion Treatment

Pleural Effusion Treatment Appointment

Why Choose PACE Hospitals for Pleural Effusion Treatment?

Pleural effusion treatment hospital in Hyderabad | Top hospital for pleural effusion treatment in Hyderabad, India
Advanced pleural effusion diagnosis using chest X-ray and modern imaging techniques

Advanced Diagnostic Facilities: Chest X-ray, Ultrasound, CT Scan, Thoracentesis & Pleural Fluid Analysis 

Expert care for malignant, loculated, and bilateral pleural effusion conditions

Expert Pulmonologists in Hyderabad for Comprehensive Pleural Effusion Management

Comprehensive management for mild, right-sided, left-sided, and complex pleural effusion cases

Personalized Pleural Effusion care with Thoracentesis, Drainage, Pleurodesis & Management of Underlying Conditions

Affordable pleural effusion treatment in Hyderabad by experienced specialists

24x7 Respiratory Support and Transparent Pleural Effusion Treatment with Insurance & Cashless Options

Recognized for excellence in healthcare delivery with

NABH, NABL, NBE/DNB, NABH Nursing Excellence, and ISCCM accreditations.

Pleural Effusion diagnosis in Hyderabad, Telangana, India

Pleural Effusion Diagnosis

The diagnosis of pleural effusion depends on the patient's medical history, presenting symptoms, and physical examination, which help the Pulmonologist determine the underlying cause and guide appropriate treatment. Pulmonologists often work with radiologists and pathologists to confirm the diagnosis and analyse pleural fluid characteristics. 

The following aspects are considered before selecting suitable diagnostic tests for pleural effusion.

  • Medical history
  • Physical examination

Medical history

A thorough medical history is a key first step in diagnosing pleural effusion. 

  • The Pulmonologist begins by asking about the patient’s presenting symptoms, such as dyspnea (shortness of breath), chest pain (especially if it worsens during breathing or coughing), persistent cough, or unexplained fatigue.
  • The duration and progression of these symptoms provide clues about whether the effusion developed suddenly (as in infection or pulmonary embolism) or gradually (as in cancer or heart failure).
  • Past medical conditions are very important. A history of heart failure, liver cirrhosis, or kidney disease suggests transudative pleural effusion, caused by fluid leakage due to pressure changes.
  • A history of pneumonia, tuberculosis (TB), malignancy, or autoimmune diseases points toward exudative pleural effusion, resulting from inflammation or infection. 
  • The doctor also reviews previous surgeries, chest trauma, radiation therapy, or certain medications, which can cause pleural involvement. 
  • Occupational or environmental exposures (asbestos, silica, or dust) and lifestyle habits such as smoking are noted, as they increase the risk of lung or pleural diseases.


Physical examination

The physical examination helps confirm the suspicion of pleural effusion and estimate the amount of fluid present. 

  • The doctor begins by observing the patient’s breathing pattern — shallow, rapid breathing or visible distress may indicate a large effusion. On inspection, one side of the chest may appear enlarged or move less during breathing if fluid restricts lung expansion.
  • After this, palpation is performed to feel chest vibrations (tactile fremitus) when the patient speaks; these vibrations are reduced or absent over areas containing fluid. 
  • During percussion (tapping on the chest wall), the affected area produces a dull, flat sound, unlike the resonant sound of healthy lung tissue. This dullness helps locate the upper border of the fluid.
  • Auscultation (listening with a stethoscope) reveals decreased or absent breath sounds over the fluid-filled area, while just above the effusion, bronchial breath sounds or a pleural rub may be heard.
  • In severe cases, the doctor may notice tracheal deviation to the opposite side, reduced chest expansion, or signs of low oxygen levels such as bluish lips or fingertips. 
  • When these findings are combined with medical history, they strongly indicate pleural effusion and guide the doctor to confirm the diagnosis through imaging tests like chest X-ray, ultrasound, or CT scan, followed by thoracentesis for fluid analysis.

✅Pleural Effusion Tests

Depending upon the medical history and physical examination, the physician may recommend diagnostic testing to confirm pleural effusion. The following tests are frequently used in the diagnostic process:

  • Imaging studies
  • Chest radiograph(X-ray)
  • Thoracic ultrasound
  • Chest computed tomography (CT scan)
  • Echocardiogram
  • Thoracentesis (pleural fluid aspiration)
  • Pleural fluid analysis
  • Light’s criteria (with serum protein, serum LDH)
  • pH level
  • Pleural fluid glucose levels
  • Fluid cell count differential
  • Fluid gram stain and culture
  • Cytological testing
  • Laboratory tests
  • Complete blood count with differential
  • Serum electrolytes
  • Serum urea and creatinine
  • Liver function tests
  • Condition-specific markers
  • Acid-fast bacilli smear
  • Mycobacterium tuberculosis culture
  • NT-proBNP (B-type natriuretic peptide)
  • Adenosine deaminase (ADA)
  • Amylase
  • Pleural fluid triglycerides
  • Pleural fluid haematocrit
  • Additional/invasive diagnostic tests
  • Pleural biopsy
  • Medical thoracoscopy (pleuroscopy)

Imaging Studies

Imaging studies play a central role in the confirmation and assessment of pleural effusion. They provide a valuable visualisation of the presence, size, location, and potential underlying cause of fluid accumulation in the pleural cavity. The main pleural effusion imaging techniques include:

Chest radiograph (X-ray)

  • Chest x-ray is considered the first imaging test used to detect pleural effusion. An upright posteroanterior (PA) chest X-ray shows pleural fluid as blunting of the costophrenic angle and a characteristic meniscus sign indicating fluid accumulation usually >200 mL. 
  • Lateral decubitus X-rays can detect up to 50 mL of fluid by showing layering fluid against the dependent pleura. Supine films are less sensitive as fluid collects posteriorly, appearing as a veil-like opacity, which may mask effusions.

Thoracic ultrasound

  • Thoracic ultrasonography is the more sensitive than X-rays for detecting pleural fluid, especially with small amounts. It aids in the detection of effusion and guides thoracentesis to safely remove fluid. 
  • On ultrasound, pleural fluid appears as a hypoechoic (dark) area. Ultrasound can also identify whether the fluid is simple or complex (e.g., septations or loculations in empyema).

Chest computed tomography (CT) scan

  • CT scan gives a detailed cross-sectional view of the chest, clearly identifying pleural fluid and underlying lung or pleural pathology, such as tumours, infections, or thickening. 
  • CT is particularly useful when chest X-ray or ultrasound findings are inconclusive or when additional information about the cause is needed.

Echocardiogram

  • An echocardiogram is conducted when pleural effusion is suspected to be caused by a cardiac problem, such as congestive heart failure (CHF) or pericardial disease. 
  • It helps evaluate the heart’s pumping function, valvular abnormalities, and the presence of pericardial effusion (fluid around the heart), which may coexist with pleural effusion. 
  • By identifying heart dysfunction, it supports the diagnosis of transudative pleural effusion due to cardiac causes.

Thoracentesis (pleural fluid aspiration)

  • Thoracentesis is a key diagnostic procedure for pleural effusion. It procedure involves inserting a needle or catheter through the chest wall into the pleural space to withdraw accumulated fluid. 
  • This helps in confirming the presence of pleural fluid and provides a sample for detailed analysis to determine the cause of the effusion.


Pleural fluid analysis

Fluid examination is the main part of pleural effusion diagnosis following thoracentesis. It aids in determining the nature of the fluid, distinguishing between transudative and exudative effusions, and identifying the underlying cause. The analysis includes many biochemical, cytological, and microbiological tests, as stated below:

Light’s criteria: Light’s criteria for pleural effusion differentiate exudative from transudative pleural effusions by comparing pleural fluid and serum protein and lactate dehydrogenase (LDH) levels. An effusion is exudative if it meets any of these:

  • Pleural fluid protein/serum protein ratio > 0.5
  • Pleural fluid LDH/serum LDH ratio > 0.6
  • Pleural fluid LDH > two-thirds the upper limit of normal serum LDH

This differentiation is important because transudative effusions usually result from systemic conditions (e.g., heart failure, cirrhosis, nephrotic syndrome), while exudative effusions indicate local inflammation or injury (e.g., pneumonia, tuberculosis, malignancy).

Serum protein levels

Serum protein levels are measured alongside pleural fluid protein to apply Light’s criteria. Elevated protein levels in pleural fluid relative to serum indicates an exudative effusion, suggesting inflammation, infection, or tumour activity within the pleural space.

Serum LDH (lactate dehydrogenase)

Light's criteria also consider LDH levels. High pleural fluid LDH levels are caused by cell breakdown and inflammation, which is prevalent in pneumonia, tuberculosis, pulmonary embolism, or malignancy. LDH is also an indicator of disease activity, the higher the value, the more active the inflammatory process.

pH level

Pleural fluid pH assists in identifying complicated effusions.

  • Normal pleural fluid pH: Around 7.60–7.64
  • Transudates: Usually have a pH between 7.40–7.55
  • Exudates: Generally, <7.30 due to inflammation, infection, or malignancy
  • A pH <7.20 strongly suggests empyema, esophageal rupture, or rheumatoid effusion and indicates the need for urgent drainage.

Pleural fluid glucose levels

Low pleural fluid glucose (< 60 mg/dL) suggests increased glucose consumption by bacteria, white blood cells, or malignant cells.

Common pleural effusion causes include:

Fluid cell count and differential

Examining the number and types of cells in the pleural fluid helps identify the cause:

  • Neutrophil-predominant fluid: This suggests acute infection (e.g., bacterial pneumonia).
  • Lymphocyte-predominant fluid: This points toward tuberculosis, malignancy, or chronic effusions.
  • Eosinophils (>10%): This may indicate air or blood in the pleural space.

Fluid gram stain and culture

Gram staining and culture detect microbial infection in the pleural fluid.

Gram-positive or Gram-negative bacteria confirm bacterial pneumonia or empyema.

Cytological testing

Examining pleural effusion fluid cytology for malignant cells helps diagnose malignant pleural effusions from primary or metastatic cancers. It also provides prognostic information and can direct further oncological investigation and management.


Laboratory Tests 

Laboratory tests are critical in analysing pleural effusion because they provide valuable information about the patient's overall health, identify systemic causes, and aid in identifying potential underlying diseases.

Lab tests for pleural effusion are:

Complete blood count with differential

A CBC with differential helps identify systemic signs related to pleural effusion.

  • Leukocytosis (high white blood cell count): This suggests infection, such as parapneumonic effusion or empyema.
  • Neutrophil predominance: This indicates acute bacterial infection.
  • Lymphocytosis: This points toward tuberculosis or malignancy.
  • Anaemia: This may occur in chronic diseases or malignancy.

Serum electrolytes

Serum electrolytes (sodium, potassium, chloride, bicarbonate) help assess fluid and electrolyte balance and identify systemic conditions leading to transudative effusions.

  • Hyponatremia and hypoalbuminemia may occur in liver cirrhosis or nephrotic syndrome, both common causes of transudative pleural effusion.
  • Abnormal electrolyte levels indicating kidney dysfunction, dehydration, or heart failure, which can indirectly lead to pleural fluid buildup. 

Serum urea and creatinine

These tests evaluate kidney function and are particularly important when uremic pleuritis (pleural inflammation due to renal failure) is suspected. Raised urea and creatinine levels suggest kidney dysfunction, which can result in pleural effusion from fluid overload or uremic inflammation. 

Liver function tests (LFTs)

These liver function tests assess the functioning of the liver through measurements of bilirubin, transaminases (AST, ALT), alkaline phosphatase, and albumin.

  • Low serum albumin reduces plasma oncotic pressure, leading to transudative pleural effusion (as seen in liver cirrhosis or nephrotic syndrome).
  • Elevated bilirubin and liver enzymes suggest hepatic hydrothorax, a transudative effusion resulting from portal hypertension in chronic liver disease.
  • LFTs also help identify metastatic liver disease, which can cause secondary pleural effusion.


Condition-Specific Markers

These markers are specialised tests performed on pleural fluid to determine the exact cause of pleural effusion when routine analysis is not sufficient. These markers help identify infections, heart failure, pancreatic diseases, or traumatic injuries as the source of pleural fluid accumulation.

Acid-fast bacilli smear

This test detects acid-fast bacteria like Mycobacterium tuberculosis in pleural fluid, helping diagnose tuberculous pleural effusion.

Mycobacterium tuberculosis culture

Culturing pleural fluid confirms tuberculosis infection by growing the bacteria, providing a definitive diagnosis.

NT-proBNP (B-type natriuretic peptide)

  • This test measures NT-proBNP in pleural fluid and helps identify heart failure–related effusions.
  • Elevated NT proBNP (> 1,500 pg/mL) strongly suggests a transudative pleural effusion due to CHF, even if Light’s criteria classify it as exudative (which can happen after diuretic therapy).

Adenosine deaminase (ADA)

High ADA activity in pleural fluid is strongly suggestive of tuberculous pleuritis and helps differentiate it from other exudative effusions.

Amylase

Elevated pleural fluid amylase is associated with pancreatitis-related effusions, esophageal rupture, or malignancy, indicating pancreatic or esophageal involvement.

Pleural fluid triglycerides

  • Measurement of triglycerides in pleural fluid helps diagnose chylothorax, which results from leakage of lymphatic fluid (chyle) into the pleural cavity. 
  • This condition is caused by trauma, thoracic surgery, or malignancies such as lymphoma that damage the thoracic duct.

Pleural fluid haematocrit

A pleural fluid haematocrit of more than 50% of the serum haematocrit confirms hemothorax, indicating blood accumulation in the pleural space.


Additional/invasive Diagnostic Tests 

When the cause of pleural effusion remains uncertain after routine imaging, pleural fluid analysis, and laboratory tests, invasive diagnostic procedures are performed. These tests allow direct visualisation and sampling of pleural tissue or fluid and are particularly valuable in diagnosing TB, malignancy, and unexplained chronic pleural effusions.

Pleural biopsy

A pleural biopsy is the removal of a small sample of the pleural membrane (the lining that surrounds the lungs and chest wall) for histological investigation. It can be done using a needle biopsy (closed pleural biopsy) or under image guidance (ultrasound/CT).

  • Tuberculous pleural effusion: Histology indicates granulomatous inflammation with caseous necrosis, and tissue cultures can yield M. tuberculosis. 
  • Malignant pleural effusion: The biopsy can reveal cancerous cells, confirming malignancy when cytology of pleural fluid is negative.

Medical thoracoscopy (pleuroscopy)

This procedure allows direct visualisation of the pleura to identify abnormalities such as nodules or plaques and enables targeted biopsies. Medical thoracoscopy has a high diagnostic yield for malignant, infectious, or inflammatory pleural diseases.

✅Stages of Pleural Effusion

Pleural effusion can develop in different stages, particularly in parapneumonic or inflammatory pleural effusions. Knowing these stages helps inform the right treatment:

  • Exudative stage
  • Fibrinopurulent stage
  • Organising stage

Exudative stage

In this initial stage, which occurs in the first few days of an infection like pneumonia. During this stage, the pleural space fills with a thin, watery fluid (exudate) that is rich in proteins and white blood cells. This is a response to inflammation in the lungs, which causes capillaries in the pleura to become more permeable and leak fluid. At this point, the effusion is uncomplicated, and the pleural fluid is not infected. It can be resolved with antibiotics alone.


Fibrinopurulent stage

If the infection continues, the effusion advances to the fibrinopurulent stage, which usually occurs five to ten days after the initial infection. Bacteria invade the pleural space, causing the fluid to thicken and turn purulent, or pus-like. The body's inflammatory response leads to the deposition of sticky fibrin on the pleural surfaces, which can create pockets of trapped, infected fluid, known as loculations. At this stage, antibiotics alone are usually insufficient, and drainage of the infected fluid is necessary.


Organising stage

The organising stage is the final, most severe stage of a pleural effusion caused by infection. In this phase, fibroblasts form a thick, inelastic pleural peel around the lung. This peel traps the lung and prevents it from fully expanding, leading to breathing problems. Surgery, called decortication, is often needed to remove the peel and restore lung function.

✅Pleural Effusion Differential Diagnosis

The differential diagnosis for pleural effusion is extensive and requires evaluating the patient's history, symptoms, and the characteristics of the pleural fluid to determine the underlying cause. The first crucial step is to classify pleural effusion as either a transudate or an exudate using Light's criteria. 

The following conditions need to be considered as possible differential diagnoses:

  • Transudate Effusion
  • Cirrhosis 
  • Congestive heart failure (CHF) 
  • Pulmonary embolism (PE) 
  • Nephrotic syndrome 
  • Exudate Effusion
  • Bacterial infections (e.g., pneumonia, sepsis) 
  • Tuberculosis (TB) 
  • Viral infections 
  • Fungal and parasitic infections 
  • Pancreatitis 
  • Peritonitis

Transudate Effusion

Cirrhosis: It causes pleural effusions primarily through hepatic hydrothorax, resulting from translocation of ascitic fluid from the peritoneal cavity to the pleural space due to diaphragmatic defects and increased hydrostatic pressure from portal hypertension.

Congestive heart failure (CHF): Increased hydrostatic pressure in the pulmonary circulation leads to transudative pleural effusions due to fluid leakage into the pleural space from the capillaries.

Pulmonary embolism (PE): It can cause pleural effusion by infarction or inflammation of the pleura, resulting in either transudative or exudative effusion depending on severity and associated tissue damage.

Nephrotic syndrome: This renal condition causes hypoalbuminemia, leading to decreased plasma oncotic pressure and consequent transudation of fluid into the pleural space.


Exudate effusion

Bacterial infections (e.g., sepsis, pneumonia): These infections cause pleural inflammation, increasing capillary permeability and resulting in exudative pleural effusions, often parapneumonic or empyematous.

Tuberculosis (TB): TB pleuritis causes granulomatous inflammation of the pleura, leading to exudative effusion rich in lymphocytes and proteins.

Viral infections (respiratory, hepatic, cardiac): Viral illnesses can cause inflammation of the pleura and subsequent exudative effusion, often self-limiting but sometimes requiring intervention.

Fungal and parasitic infections: These less common infections cause exudative effusions by direct pleural invasion or immune-mediated inflammation.

Pancreatitis: Enzymatic leakage and inflammation extend into the pleura, causing exudative effusion typically on the left side.

Peritonitis: Inflammatory fluid from peritoneal infection or inflammation may track into the pleural space, causing reactive pleural effusion, often transudative or exudative depending on the etiology.

✅Consideration of a pulmonologist before treating pleural effusion

These considerations are crucial for a pulmonologist before initiating treatment for pleural effusion to ensure a comprehensive, individualised, and effective management plan:

  • Assessment of underlying cause: The Pulmonologist evaluates whether the effusion is transudative or exudative through diagnostic procedures, laboratory analysis, and imaging, to identify the root pathology, such as infection, heart failure, or malignancy.
  • Distinguishing exudates from transudates: A key step is differentiating between transudative and exudative effusions, which is critical for guiding treatment. 
  • Assessment of surgical eligibility: For certain cases (e.g., recurrent or complicated effusions), the Pulmonologist considers the need for advanced interventions such as thoracoscopic procedures or pleurodesis, especially in patients with comorbidities or contraindications for surgery.
  • Evaluation of patient's overall health: Comorbidities like COPD, heart failure, or coagulopathies influence treatment decisions, including the safety of invasive procedures or aspiration limits to avoid complications like re-expansion pulmonary edema.

✅Pleural Effusion Treatment Goals

The treatment goals of pleural effusion are:

  • To remove the excess fluid: This provides symptomatic relief, such as shortness of breath (SOB) and chest pain. Procedures like thoracentesis, chest tube drainage, or indwelling pleural catheters are employed to evacuate accumulated pleural fluid.
  • To prevent re-accumulation of fluid: Measures such as chemical pleurodesis (inducing adhesion between pleural layers to obliterate the pleural space) or placement of indwelling catheters help prevent recurrence, particularly in cases of malignant or recurrent effusions.
  • To treat the underlying cause: Effective management also focuses on addressing the root pathology causing the effusion, such as optimising heart failure therapy, administering antibiotics for infections, managing malignancies, or treating liver or kidney diseases, which can stop further fluid buildup.

Need clarity on pleural effusion diagnosis or treatment options?

Get a free second opinion from our expert team.

At PACE Hospitals, we are committed to providing our patients with the best possible care, and that includes offering second medical opinions with super specialists for treatment or surgery. We recommend everyone to get an expert advance medical second opinion, before taking decision for your treatment or surgery.

A pulmonologist may choose the pleural effusion treatment depending on the severity of symptoms, type of pleural effusion, underlying causes, and overall patient condition. Several options are available for managing pleural effusion. The most common interventions include:

  • Non-pharmacological management
  • Observation
  • Supportive care
  • Oxygen therapy
  • Nutritional support
  • Lifestyle modifications
  • Breathing exercises and physiotherapy
  • Medical management of pleural effusion
  • For transudative effusions (management of underlying cause)
  • Diuretics
  • ACE inhibitors or beta-blockers 
  • Albumin infusion
  • For exudative effusion(management of underlying cause)
  • Antibiotics
  • Corticosteroids
  • Immunosuppressants
  • Antitubercular drugs
  • Chemotherapy/ targeted therapy
  • Surgical and interventional management
  • Therapeutic thoracentesis (pleural fluid drainage)
  • Chest tube drainage(intercostal tube)
  • Intrapleural fibrinolysis agents
  • Pleurodesis (sclerosing agents)
  • Indwelling pleural catheter (IPC)
  • Video-assisted thoracoscopic surgery (VATS)
  • Decortication (for empyema/fibrothorax)
  • Medical thoracoscopy (pleuroscopy)
  • Pleuroperitoneal shunt
  • Thoracic duct ligation(for chylothorax)

Non-pharmacological Management

Non-pharmacological treatment focuses on symptom relief, supporting recovery, and preventing complications. These measures are: 

Observation

Small, asymptomatic pleural effusions can be closely monitored without instant intervention, allowing spontaneous resolution while regularly assessing symptoms and effusion size to avoid unnecessary therapy.

 

Supportive care

  • Oxygen therapy: Used to improve oxygenation in patients experiencing respiratory distress from lung compression by pleural fluid.
  • Nutritional support: Ensures adequate nutrition, which supports immune function and healing, particularly important in chronic or malignant effusions.


Lifestyle modifications

Lifestyle changes like avoiding smoking, managing other health issues like heart failure or liver disease, and keeping up with hydration and physical activity can help reduce fluid buildup and improve overall health.


Breathing exercises and physiotherapy

These help maintain lung expansion, improve ventilation, prevent atelectasis (the partial or complete collapse of a lung), and enhance mucus clearance. Physiotherapy may aid recovery post-drainage, improve respiratory muscle strength, and reduce dyspnea symptoms.


Medical Management of Pleural Effusion

Pleural effusion treatment focuses on treating the underlying cause and resolving the fluid accumulation. The management differs for transudative and exudative effusions, depending on whether the cause is systemic or local.

For transudative effusions (management of underlying cause)

  • Diuretics: Diuretics are medications that aid in removing excess accumulated fluid from the body by promoting urine production. They are mainly used in congestive heart failure, renal failure, and liver disease, where excess fluid leads to pleural effusion. By reducing intravascular volume and hydrostatic pressure, diuretics decrease the amount of fluid that leaks into the pleural space.
  • ACE inhibitors or beta-blockers
  • ACE inhibitors: These reduce pressure by relaxing blood vessels, which lowers the heart's workload and prevents fluid from leaking into the lungs.
  • Beta-blockers: These slow down the heart rate, making it pump more efficiently and reducing the overall strain on the heart.
  • Albumin infusion: Patients with nephrotic syndrome or liver cirrhosis may have low blood albumin levels. This can reduce oncotic pressure and allow fluid to escape into tissues and pleural spaces. Infusing albumin helps restore plasma protein levels. This restores oncotic pressure and prevents further accumulation of pleural fluid.


For exudative effusion

  • Antibiotics: Antibiotics are used for infectious effusions (parapneumonic effusions and empyema), antibiotics directly kill the bacteria in the pleural space. Studies show that many antibiotics achieve effective concentrations in pleural fluid, especially when the infection is still in its early stages.
  • Corticosteroids: These are powerful anti-inflammatory agents. While not for all exudates, they can be used for specific inflammatory conditions, such as tuberculous pleurisy, to suppress the immune response that drives fluid accumulation and help fluid clear more quickly.
  • Immunosuppressants: These are used for exudative effusions linked to autoimmune disorders like systemic lupus erythematosus (SLE). By dampening the overall immune system, they reduce the inflammatory attack on the pleura that is causing the effusion.
  • Antitubercular drugs: A specific combination of drugs is used to treat pleural effusions caused by tuberculosis. They kill the M. tuberculosis bacteria, thereby resolving the infection and associated inflammation.
  • Chemotherapy/targeted therapy: For malignant effusions, these therapies target the cancer cells that are invading the pleura or blocking lymphatic drainage. By shrinking the tumour, these agents can help reduce or stop the fluid production.


Surgical and Interventional Management of Pleural Effusion

When pleural effusion is large, recurrent, loculated, or unresponsive to medical therapy, surgical and interventional procedures are used to remove the fluid, restore lung expansion, and prevent recurrence. 

These procedures are:

Therapeutic thoracentesis (pleural fluid drainage)

A minimally invasive, bedside procedure that uses a needle to drain excess fluid from the pleural space. It is performed for both diagnostic and therapeutic purposes, providing immediate symptom relief for large effusions causing shortness of breath or pain.


Chest tube drainage (intercostal tube)

In cases of large, infected or loculated effusions such as empyema, a chest tube (thoracostomy tube) is inserted into the pleural cavity for continuous drainage. This procedure ensures that pus, blood, or thick fluid is completely evacuated, allowing the lung to expand. 


Intrapleural fibrinolysis agents

For complex, loculated (pouchy) effusions or empyema, these agents, such as alteplase and DNase, are instilled directly into the pleural space via a chest tube. Fibrinolytic drugs break up the fibrin strands that create loculations, allowing for more effective drainage of infected pus.


Pleurodesis (sclerosing agents)

Pleurodesis is a procedure done to prevent recurrent pleural effusion, especially in malignant or chronic effusions. A sclerosing agent is introduced between the two layers of the pleura, sealing off the pleural space and preventing fluid from reaccumulating. 


Indwelling pleural catheter (IPC)

A long-term catheter is placed to allow for intermittent fluid drainage at home by the patient or caregivers. IPCs are a palliative option for recurrent effusions, especially malignant ones, that do not respond to pleurodesis or occur with a "trapped lung".


Video-assisted thoracoscopic surgery (VATS)

VATS is a minimally invasive surgical technique performed under general anaesthesia. A tiny incision to drain pleural fluid, remove fibrous tissue, or perform biopsies. VATS is useful for complex or recurrent pleural effusions, loculated empyema, and malignant pleural disease.


Decortication (for empyema/fibrothorax)

This surgery removes a thick, fibrous peel that can form over the lung, most often in the late stages of empyema. By removing this restrictive layer, decortication allows the trapped lung to re-expand and improves respiratory function.


Medical thoracoscopy (pleuroscopy)

A less invasive procedure where an endoscope is inserted into the pleural space under local anaesthesia and sedation. It allows for direct visualisation to aid in diagnosis, perform targeted biopsies, break down septations, and administer talc for pleurodesis.


Pleuroperitoneal shunt

A pleuroperitoneal shunt is a special device that transfers pleural fluid from the pleural cavity into the peritoneal (abdominal) cavity, where it can be absorbed naturally. This procedure is used for recurrent effusions when pleurodesis or catheter drainage is not suitable.


Thoracic duct ligation(for chylothorax)

This surgical procedure is used specifically for chylothorax, a type of effusion caused by lymphatic fluid. If dietary changes fail, the thoracic duct is surgically ligated to stop the leak of lymphatic fluid into the pleural space.

Pleural Effusion Prognosis

The prognosis of pleural effusion largely depends on its underlying cause and the stage of the disease at diagnosis. 

  • Early diagnosis and timely treatment are linked with better outcomes and fewer complications. Morbidity and mortality are higher when pleural effusion is caused by serious conditions like pneumonia, tuberculosis, or cancer. 
  • Patients with pneumonia and pleural effusion generally have worse outcomes than those with pneumonia alone. Prompt treatment of parapneumonic effusions usually leads to full recovery, while untreated cases may progress to empyema, fibrosis, or sepsis.
  • Malignant pleural effusion (MPE) carries a poor prognosis, with a median survival of around 3–12 months, depending on the type of cancer. 
  • Lung cancer is the most common cause in men, and breast cancer in women. Cancers more sensitive to chemotherapy, such as lymphoma or breast cancer, are linked with longer survival compared to lung cancer or mesothelioma. 
  • Additionally, a lower pleural fluid pH often indicates a higher tumour load and a worse prognosis.

Pleural Effusion Treatment Cost in Hyderabad, India

The cost of Pleural Effusion Treatment in Hyderabad generally ranges from ₹15,000 to ₹3,50,000 and above (approx. US $180 – US $4,210).

The exact cost of pleural effusion treatment depends on the severity of the condition, the underlying cause (e.g., infection, cancer, heart failure), and the type of treatment required (medication, thoracentesis, or surgery). Additional factors such as diagnostic tests (X-ray, ultrasound, CT scan), hospitalization requirements, surgical interventions, and post-treatment care will influence the total cost. Availability of cashless treatment options, TPA corporate tie-ups, and insurance assistance may further affect expenses.


Cost Breakdown According to Type of Pleural Effusion Treatment

  • Medical Management (Medication & Monitoring) – ₹15,000 – ₹30,000 (US $180 – US $360)
  • Thoracentesis (Pleural Fluid Drainage) – ₹20,000 – ₹50,000 (US $240 – US $600)
  • Pleural Effusion Treatment with Chest Tube Insertion – ₹30,000 – ₹70,000 (US $360 – US $840)
  • Pleural Effusion Surgery (Video-Assisted Thoracoscopic Surgery - VATS or Decortication) – ₹1,00,000 – ₹2,50,000 (US $1,205 – US $3,010)
  • Pleural Effusion Due to Cancer (with Chemotherapy or Radiotherapy) – ₹2,00,000 – ₹3,50,000+ (US $2,410 – US $4,210+)

Frequently Asked Questions (FAQs) on Pleural Effusion

  • Can pleural effusion cause cancer?

    Pleural effusion itself does not directly cause cancer. However, some effusions occur because cancer cells have spread to the pleura, making fluid build up. Such “malignant pleural effusions” are often seen in people with certain cancers like lung, breast, or ovarian cancer.

  • Which Is the Best Hospital for Pleural Effusion Treatment in Hyderabad, India?

    PACE Hospitals, Hyderabad, is a trusted centre for the diagnosis and management of pleural effusion and other respiratory conditions.


    We have highly experienced pulmonologists, thoracic surgeons, and critical care specialists who follow evidence-based protocols to diagnose and treat pleural effusion effectively, focusing on the underlying cause, fluid drainage, and long-term management.


    We provide excellent facilities including state-of-the-art diagnostic imaging (X-ray, CT scan, ultrasound), advanced thoracentesis techniques, video-assisted thoracoscopic surgery (VATS), and a well-equipped ICU, PACE Hospitals ensures comprehensive and patient-centred pleural effusion treatment.

  • Who is most at risk for pleural effusion?

    People with underlying heart, kidney or liver diseases are at higher risk for pleural effusion due to fluid imbalance. Those with lung infections, tuberculosis, or cancers such as lung and breast cancer are also more prone. Other risk factors include chronic smokers, individuals exposed to asbestos, and people with autoimmune diseases or weakened immunity.

  • What Is the Cost of Pleural Effusion Treatment at PACE Hospitals, Hyderabad?

    At PACE Hospitals, Hyderabad, the cost of pleural effusion treatment typically ranges from ₹12,000 to ₹3,00,000 and above (approx. US $145 – US $3,610), making it a cost-effective and competitive option for pleural effusion care in Hyderabad. However, the final cost depends on:

    • Severity and underlying cause of the pleural effusion (infection, cancer, heart failure)
    • Type of treatment required (medication, thoracentesis, chest tube, or surgery)
    • Diagnostic tests (X-ray, ultrasound, CT scan, pleural fluid analysis)
    • Duration of hospitalization and postoperative care
    • Surgical or interventional procedures required (VATS, decortication)

    For mild pleural effusion, treatment costs remain toward the lower end, while complicated or recurrent pleural effusions requiring surgery may fall toward the higher range.


    After a detailed clinical evaluation, diagnostic imaging, and fluid analysis, our specialists provide a transparent cost estimate tailored to the patient’s condition and treatment plan.

  • What is the survival rate of malignant pleural effusion?

    Malignant effusion is usually a sign that cancer has spread and is advanced. The survival rate varies depending on the type and stage of the original cancer. Generally, the average survival after diagnosis is between 3 and 12 months, but this can differ based on treatment, the person’s general health, and cancer type.

  • Looking for the Best Pleural Effusion Treatment Hospital Near Me?

    If you’re searching for the top pleural effusion treatment hospital near me in areas like HITEC City, Madhapur, Kondapur, Gachibowli, Kukatpally, or KPHB, it is important to choose a hospital with experienced pulmonologists and advanced diagnostic and treatment technologies for respiratory disorders.

    Effective pleural effusion treatment requires:

    • Accurate diagnosis through imaging (X-ray, ultrasound, CT scan)
    • Thoracentesis or chest tube drainage for fluid removal
    • Surgical intervention (VATS, decortication) when needed

    Ongoing monitoring and rehabilitation

    At PACE Hospitals, Hyderabad, patients receive comprehensive care with a multidisciplinary approach, ensuring optimal recovery and prevention of recurrence.

What is pleural effusion?

Pleural effusion is a medical condition in which excess fluid accumulates in the pleural space (the narrow gap between the lungs and the chest wall). Normally, a small quantity of fluid helps the lungs flow easily when breathing. When the balance between fluid production and removal is disrupted, fluid accumulates, resulting in , chest pain, breathing difficulties, or cough.

What are the types of pleural effusion?

Pleural effusion is mainly classified as transudative or exudative based on the nature of the fluid. Transudative effusion occurs due to fluid leakage from increased pressure or low protein levels in the blood, often caused by heart failure or liver cirrhosis. Exudative effusion results from inflammation or injury, making the fluid rich in proteins and cells..

What is a right-sided pleural effusion, and what causes it?

Right-sided pleural effusion means that fluid has accumulated on the right side of the chest cavity. It often occurs due to heart failure, liver disease (hepatic hydrothorax), pneumonia, or cancer affecting the right lung. The right side is more frequently affected because of lymphatic drainage patterns and liver-related conditions that allow fluid to pass through small openings in the diaphragm.

Why does pleural effusion occur in tuberculosis?

In tuberculosis (TB), pleural effusion develops when the body’s immune system reacts to Mycobacterium tuberculosis bacteria near the pleura. The infection causes inflammation and fluid leakage into the pleural space. This fluid usually contains immune cells and proteins as the body attempts to fight the infection.

How does congestive heart failure cause pleural effusion?

In congestive heart failure (CHF), the heart’s pumping ability weakens, causing fluid to back up into blood vessels. This increases pressure in the lungs’ blood vessels, pushing fluid into the pleural space. Most often, the fluid is clear and low in protein, known as transudate. CHF usually causes effusions on both sides, but can be larger on the right.

Can pleural effusion spread?

Pleural effusion itself is not contagious and cannot spread from one person to another. However, the cause of the effusion may spread. For example, tuberculosis or pneumonia can spread through infection, and cancer cells may spread within the body to reach the pleura. The fluid accumulation is a result, not a spreading disease.

What causes transudative pleural effusion?

Transudative pleural effusion occurs when fluid leaks into the pleural space due to an imbalance in pressure or protein levels in blood vessels. It is not caused by inflammation. Common causes include congestive heart failure, liver cirrhosis, and kidney disease. These conditions increase pressure in blood vessels or reduce blood protein, allowing clear, low-protein fluid to pass into the pleural space.

What is a loculated pleural effusion?

Loculated pleural effusion refers to fluid that becomes trapped in one area of the pleural space instead of moving freely. This occurs when inflammation leads to fibrous tissue formation, dividing the fluid into separate pockets. It is often seen in infections such as pneumonia or tuberculosis and may make drainage difficult.

How does breast cancer cause pleural effusion?

Breast cancer can cause pleural effusion when cancer cells spread through the bloodstream/ lymphatic system to the pleura. The cancer cells irritate the pleural lining, leading to inflammation and increased fluid production. Additionally, blocked lymphatic drainage prevents normal fluid removal, worsening the buildup.

Does pleural effusion cause coughing?

Yes, pleural effusion can cause coughing. The excess fluid in the pleural space compresses the lungs, reducing their ability to expand fully during breathing. This irritation or pressure on the airways can trigger a persistent, dry cough. The cough may get worse when lying down or during physical activity.

Which doctor is best for pleural effusion?

A pulmonologist (lung specialist) is the best doctor to diagnose and manage pleural effusion. They specialise in diseases of the lungs and chest cavity, and perform procedures such as thoracentesis to remove fluid. In some cases, treatment may also involve oncologists for cancer-related effusions, infectious disease specialists for tuberculosis, or cardiologists for heart-related causes.

Is Pleural Effusion Treatment Covered by Insurance at PACE Hospitals?

Yes, pleural effusion treatment is generally covered under most health insurance policies at PACE Hospitals, subject to policy terms and approval. Since pleural effusion can result from both benign and malignant conditions and often requires hospitalization, fluid drainage, or surgery, it is typically included under private insurance and corporate health plans.

At PACE Hospitals, patients can benefit from:

  • Cashless hospitalization facilities with empaneled insurance providers
  • Assistance from a dedicated insurance and TPA coordination team
  • Pre-authorization support and documentation guidance
  • Transparent cost estimates before admission
  • Support for government health schemes where applicable

Coverage depends on procedure clauses, sum insured limits, and policy inclusions. Patients are encouraged to share insurance details at the time of admission so the hospital’s insurance desk can verify eligibility and streamline approvals.